<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1104">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146778</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0568-001</org_study_id>
    <nct_id>NCT05146778</nct_id>
  </id_info>
  <brief_title>A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia</brief_title>
  <acronym>RELIEF</acronym>
  <official_title>A Single-blinded Randomized-controlled Study to Reduce Persistent Post-mastectomy Pain Using Multimodal Opioid-free Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 230 patients undergoing mastectomy, the investigators will compare opioid-free anesthesia&#xD;
      (OFA) versus conventional opioid-based anesthesia in terms of chronic pain. The enrolled&#xD;
      patients will be randomly assigned into two groups with 1:1 ratio. Chronic pain will be&#xD;
      evaluated at 1 year after mastectomy based on the Breast Cancer Pain Questionnaire (BCPQ).&#xD;
      Baseline pain sensitivity test and psychologic evaluation will be done before operation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study population&#xD;
&#xD;
        1. All of patients will undergo mastectomy with or without immediate breast reconstruction.&#xD;
&#xD;
        2. 230 patients will be enrolled.&#xD;
&#xD;
      Intervention&#xD;
&#xD;
        1. OFA group will be sedated using dexmedetomidine and lidocaine.&#xD;
&#xD;
        2. Conventional opioid anesthesia group will be sedated using remifentanil.&#xD;
&#xD;
      Pain screening&#xD;
&#xD;
        1. Breast Cancer Pain Questionnaire (BCPQ)&#xD;
&#xD;
        2. Pain-detect, HADS, EQ-5D, PHQ-15 (somatic symptom), PCS (pain catastrophizing), BFI (big&#xD;
           five inventory), HAM-A&amp;D, Pressure algometry (Pain sensitivity), Quantitative sensory&#xD;
           test (pinprick)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 13, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Control arm: Conventional Anesthesia with opioid&#xD;
Interventional arm: Opiod-free Anesthesia with dexmedetomidine and lidocaine</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients will be not aware of which type of anesthesia would be applied during operation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of chronic breast pain at 1 year after mastectomy</measure>
    <time_frame>1 year after mastectomy</time_frame>
    <description>Presence of chronic pain will be assessed by Breast Cancer Pain Questionnaire (BCPQ). Zero score means absence of persisting breast-related pain. The minimum and maximum values of pain scale are 0 and 11, respectively. High score means worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year after mastectomy</time_frame>
    <description>Presence of anxiety and depression symptoms will be assessed by HADS (Hospital Anxiety and Depression Scale) questionnaire. The range of each symptoms scale is between 0 and 21. A scale of 0-7 is defined as normal, a scale of 8-10 is defined as borderline, and a scale of 11-21 is defined as abnormal. High score means worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Sensitivity</measure>
    <time_frame>1 year after mastectomy</time_frame>
    <description>The type of pain will be assessed by painDetect Questionnaire (PDQ). The PDQ comprises 12 items. The first three assess current pain, strongest pain during the past 4 weeks, and average pain during the past 4 weeks on a 0-10 point numerical rating scale from &quot;none&quot; to &quot;worst imaginable&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Mastectomy</condition>
  <condition>Pain, Chronic</condition>
  <condition>Pain, Post Operative</condition>
  <arm_group>
    <arm_group_label>Opioid-free anesthesia group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OFA group will be sedated using dexmedetomidine and lidocaine during mastectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional anesthesia group with opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional opioid anesthesia group will be sedated using remi-fentanyl during mastectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Opioid-free anesthesia</intervention_name>
    <description>OFA group will be sedated using dexmedetomidine and lidocaine.</description>
    <arm_group_label>Opioid-free anesthesia group</arm_group_label>
    <other_name>Dexmedetomidine and lidocaine-based anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional opioid-based anesthesia</intervention_name>
    <description>Conventional opioid-based anesthesia group will be sedated using remi-fentanyl</description>
    <arm_group_label>Conventional anesthesia group with opioid</arm_group_label>
    <other_name>Remi-fentanyl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All of patients will undergo mastectomy with or without immediate breast&#xD;
             reconstruction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous history of breast surgery&#xD;
&#xD;
          -  Allergy to drug&#xD;
&#xD;
          -  Other cancer history&#xD;
&#xD;
          -  Underlying psychologic disorder&#xD;
&#xD;
          -  Patients with chronic pain requiring pain killers&#xD;
&#xD;
          -  Baseline SpO2 &lt;95%&#xD;
&#xD;
          -  Left ventricular EF &lt;40%&#xD;
&#xD;
          -  Bradycardia as HR &lt;50 bpm&#xD;
&#xD;
          -  BMI &gt;35kg/m2&#xD;
&#xD;
          -  Pregnant woman&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Gwe G Ahn, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gangnam Severance Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung Gwe Ahn, M.D.,Ph.D.</last_name>
    <phone>82220194402</phone>
    <email>asg2004@yuhs.ac</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Soong June Bae, M.D.</last_name>
    <phone>82220193370</phone>
    <email>mission815815@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135270</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Gwe Ahn, MD, PhD</last_name>
      <phone>82-2-2019-3370</phone>
      <email>asg2004@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Sung Gwe Ahn</investigator_full_name>
    <investigator_title>Assocaite Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

